Jeffrey B. Mirviss Power - 13 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Reporting relationship: EVP&Pres, Periph Intervent
Issuer ticker: BSX
Reported as of: 13 Feb 2025
Net transaction value: -$439,508
SEC form: 4
Accepted by SEC: 18 Feb 2025, 17:52:13 UTC
Prior SEC filing: 14 Feb 2025
Next SEC filing: 19 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Susan Thompson, Attorney-in-Fact

Key filing fact

Jeffrey B. Mirviss Power filed Form 4 for BOSTON SCIENTIFIC CORP (BSX) on 18 Feb 2025.

Key facts

This page summarizes Jeffrey B. Mirviss Power's Form 4 filing for BOSTON SCIENTIFIC CORP (BSX).
11 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 18 Feb 2025, 17:52.

Change

Previous filing in this sequence was filed on 14 Feb 2025.
Current net transaction value: -$439,508.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,776
Change %: +9.3%
Price: $0.000000
Shares after: 32,477
Date: 14 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $134,335
Shares: -1,266
Change %: -3.9%
Price: $106.11
Shares after: 31,211
Date: 14 Feb 2025
Ownership: Direct

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +2,970
Change %: +9.5%
Price: $0.000000
Shares after: 34,181
Date: 16 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $143,779
Shares: -1,355
Change %: -4%
Price: $106.11
Shares after: 32,826
Date: 16 Feb 2025
Ownership: Direct

BSX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +3,334
Change %: +10%
Price: $0.000000
Shares after: 36,160
Date: 17 Feb 2025
Ownership: Direct
Footnotes: F1

BSX transaction

Common Stock

Tax liability

Transaction value: $161,393
Shares: -1,521
Change %: -4.2%
Price: $106.11
Shares after: 34,639
Date: 17 Feb 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSX transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +5,181
Change %
Price: $0.000000
Shares after: 5,181
Date: 13 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,181
Exercise price
Footnotes: F1, F2

BSX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +13,334
Change %
Price: $0.000000
Shares after: 13,334
Date: 13 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,334
Exercise price: $106.14
Footnotes: F3

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,776
Change %: -33%
Price: $0.000000
Shares after: 5,552
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,776
Exercise price
Footnotes: F1, F4

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,970
Change %: -50%
Price: $0.000000
Shares after: 2,970
Date: 16 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,970
Exercise price
Footnotes: F1, F5

BSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -3,334
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,334
Exercise price
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

Footnote F2

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F3

Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Footnote F4

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.

Footnote F5

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.

Footnote F6

Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.